Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies

DOI: 10.5306/wjco.v9.i5.90

Keywords: FMS-like tyrosine kinase 3, Tyrosine kinase domain, Internal tandem duplication, FLT3 inhibitor, Drug resistance, Acute myeloid leukemia, Combination therapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text